Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Radioisotope production facility for use with positron emission tomography










Image Number 9 for United States Patent #5037602.

A radioisotope production facility (12) produces radioisotopes having application to Positron Emission Tomography. The radioisotopes produced include .sup.18 F, .sup.13 N, .sup.15 O, and .sup.11 C, and are produced by irradiating a selected target material (40) with a high energy .sup.3 He.sup.++ beam accelerated in a radio frequency quadruple (RFQ) linear accelerator (34). The facility includes, in addition to the RFQ linear accelerator and the selected target, a source of .sup.3 He.sup.++ ions (30), low energy transport means (32) for focusing the .sup.3 He.sup.++ beam into the RFQ linear accelerator, and a high energy transport means (36) for directing the accelerated .sup.3 He.sup.++ beam at the selected target. Further included is a target subsystem (16) that holds the target, automatically prepares precursors containing the .sup.18 F, .sup.13 N, .sup.15 O, and .sup.11 C radioisotopes, and an automated radiopharmaceutical subsystem (22) that prepares suitable radiopharmaceuticals from the desired precursors.








 
 
  Recently Added Patents
Ice scraper
For deferring invitational content
Container
Method for the production of an additive for the enzymatic decomposition of mycotoxins, additive, and use thereof
Gemstone setting
Interface plate between integrated circuits
Refined oil degradation level measuring instrument and refined oil degradation level measuring method
  Randomly Featured Patents
Hydraulic machine
Pyrimidine derivatives
Process for the plasma-catalytic production of ammonia
Interconnect for MEMS device including a viscoelastic septum
Communication protocol
Image pickup lens and image pickup apparatus
Stilt material for pressure sensitive microencapsulated coatings
Pigtailed package for an optoelectronic device
Digitoxigenin and dihydrodigitoxigenin 3.beta.-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders
Audible sound confirmation of programming an implantable medical device